Chromatography

  • From Discovery to Production of Active Biotherapeutic and Pharmaceutical Ingredients

From Discovery to Production of Active Biotherapeutic and Pharmaceutical Ingredients

Jun 19 2018 Read 918 Times

Kromasil fits across the entire biotherapeutic and pharmaceutical organisations. Typically, researchers carry out method development using Kromasil UHPLC and HPLC columns based on 1.8 - 5 μm particle sizes. Then scientists and engineers in discovery, process and manufacturing departments scale the method up according to their needs using the same Kromasil stationary phases in prepacked columns and bulk ranging from 7 to 25 μm. This Kromasil capability to supply the entire development and production path of an API is unique in the market and shortens the timeline plus minimises costs when producing a drug. With 30 years of experience, Kromasil continues to expand its list of products, provides ready-made columns as well as bulk material for normal phase, reversed phase, chiral, HILIC, SFC and SMB chromatography.

For more information go to www.kromasil.com.

Read comments0

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.


Digital Edition

Lab Asia December 2018

December 2018

In This Edition Articles - Determination of heroin in street drug samples with printable surface enhanced Raman scattering (P-SERS) - Advances in Protein Sample Preparation: Centrifugation i...

View all digital editions

Events

Arab Health

Jan 28 2019 Dubai International Convention & Exhibition Centre

Nano Tech 2019

Jan 30 2019 Tokyo, Japan

World Congress on Chromatography

Jan 31 2019 Paris, France

SLAS 2019

Feb 02 2019 Washington, DC, USA.

MEDLAB MIDDLE EAST

Feb 04 2019 Dubai, UAE

View all events